tiprankstipranks
Trending News
More News >
Mindbio Therapeutics Corp. (TSE:MBIO)
:MBIO
Canadian Market

Mindbio Therapeutics Corp. (MBIO) Financial Statements

Compare
12 Followers

Mindbio Therapeutics Corp. Financial Overview

Mindbio Therapeutics Corp.'s market cap is currently C$2.45M. The company's EPS TTM is C$; its P/E ratio is -76.43; Mindbio Therapeutics Corp. is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23
Income Statement
Total Revenue
Gross Profit--
Operating Income$ -55.95K-
EBITDA$ -56.64K$ -4.25M
Net Income$ -415.64K-
Balance Sheet
Cash & Short-Term Investments$ ―$ ―
Total Assets$ 194.17K-
Total Debt$ 5.02M$ 0.00
Net Debt$ 4.88M$ 0.00
Total Liabilities$ 5.94M-
Stockholders' Equity$ ―$ ―
Cash Flow
Free Cash Flow
Operating Cash Flow$ -383.47K-
Investing Cash Flow
Financing Cash Flow
Currency in USD

Mindbio Therapeutics Corp. Earnings and Revenue History

Mindbio Therapeutics Corp. Debt to Assets

Mindbio Therapeutics Corp. Cash Flow

Mindbio Therapeutics Corp. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.